Peptide studied in wound healing research.
Guidance only. Confirm dosing with your prescribing clinician.
Complete a quick screening to proceed
TB-500 is studied for its role in cellular migration and tissue recovery pathways in regenerative research models.
This peptide is delivered using Zenith's Dual Chamber Precision Pen, allowing automatic peptide reconstitution and accurate dosing without manual mixing.
TB-500 is a synthetic peptide fragment of thymosin beta-4, a naturally occurring protein involved in cell migration and tissue repair.
In biological research contexts, TB-500 has been studied for its role in actin regulation and wound healing processes.
This compound has been examined in veterinary and laboratory research environments.
Research literature suggests TB-500 upregulates actin expression, facilitating cellular migration and tissue regeneration.
It has been investigated for its potential influence on cardiovascular tissue repair and inflammatory response modulation.
TB-500 has been referenced in research relating to:
TB-500 is primarily used in research and veterinary applications internationally.
Injectable formats are not approved therapeutic medicines in Australia.
Information provided is for educational and research awareness purposes only.
TB-500 injectable formulations are not listed on the Australian Register of Therapeutic Goods (ARTG).
Topical cosmetic products containing this compound may be available under cosmetic regulatory frameworks.
Always consult a qualified medical professional regarding prescription medicines.
Upregulates actin for cellular migration and tissue repair
Promotes angiogenesis and reduces systemic inflammation
Studied in wound healing and cardiac tissue recovery models
This product is a general wellness formulation. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use. All formulations are compounded in Australian TGA-regulated facilities.
Complete screening to purchase
